YIN Lei
職稱（如有）：主任醫(yī)師
Email: [email protected]
Tel: 13641673203
研究方向: 兒童原發(fā)性腎病綜合征的發(fā)病機制和難治性腎病的治療
Biography
Dr. Yin Lei graduated from Shanghai Medical University with master's degree in 1997. She was awarded her Ph.D. from Shanghai Jiaotong University School of Medicine in 2017. Now she is Chief physician and the director of Nephrology Department of Shanghai Children’s Medical Center. Dr. Yin engages in the diagnosis and treatment of children's kidney diseases and autoimmune diseases, including complicated urinary tract infection, refractory nephrotic syndrome, IgA nephropathy, acute renal injury, children's hypertension, hyperuricemia, renal tubular disease, lupus nephritis, purpura nephritis, Takayasu arteritis, thrombotic microangiopathy, macrophage activation syndrome, juvenile idiopathic arthritis, dermatomyositis, etc. She also has rich clinical experience in the diagnosis of rare and complicated diseases in children. Dr. Yin once accepted training in Nephrology Department of the Royal Children's Hospital in Melbourne, Australia, Nephrology Department and the Rheumatology Department of Cincinnati Children's Hospital in the United States to study the treatment of children's refractory nephrotic syndrome, the diagnosis and treatment of autoimmune diseases, the application of biological agents and the management of children's hypertension. The research direction of Dr. Yin is the pathogenesis of primary nephrotic syndrome and the treatment of refractory nephrotic syndrome in children.
Publications
Yin L, Mao Y, Zhou Y, et al. A retrospective study of nine patients with progressive pseudorheumatoid dysplasia: to explore early diagnosis and further treatment. Clin Rheumatol. 2022;41(3):877-888. doi:10.1007/s10067-021-05959-2
Mao Y, Yin L, Huang H, et al. Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy. J Int Med Res. 2019;47(1):105-113. doi:10.1177/0300060518796751
Chen Y, Li G, Xu Y, et al. Targeted exome sequencing identified a novel mutation hotspot and a deletion in Chinese primary hypertrophic osteoarthropathy patients. Clin Chim Acta. 2018;487:264-269. doi:10.1016/j.cca.2018.10.005
Yin L, Mao Y, Song H, et al. Vincristine alleviates adriamycin-induced nephropathy through stabilizing actin cytoskeleton. Cell Biosci. 2017;7:1. Published 2017 Jan 3. doi:10.1186/s13578-016-0129-z
